Postoperative visual acuity (VA) is the factor with the most significant impact on stereopsis in paediatric unilateral pseudophakic subjects, according to study results published online ahead of print by the British Journal of Ophthalmology.
Postoperative visual acuity (VA) is the factor with the most significant impact on stereopsis in paediatric unilateral pseudophakic subjects, according to study results published online ahead of print by the British Journal of Ophthalmology.
Seung-Hyun Kim of Korea University College of Medicine, Republic of Korea and David A. Plager of Indiana University Medical Center, United States conducted a retrospective chart review of paediatric subjects undergoing unilateral cataract extraction and primary IOL implantation (n=38). Subjects were split into two groups: Group 1 subjects (n=21; stereopsis >400 seconds of arc) had a mean age of 4.9 years at presentation and 6.3 at surgery; Group 2 subjects (n=17; stereopsis <400 seconds of arc) had a mean age of 2.7 years at presentation and 3.0 at surgery. Dr Kim and Dr Plager collected data on refractive error, anisometropia, bilateral best corrected visual acuity and stereoacuity to evaluate which factors most influence stereopsis.
The data collected showed that 66.7% of Group 1 subjects and 47.1% of Group 2 subjects had no strabismus either before or after surgery. VA of 20/40 or better was achieved by 52.0% of Group 1 subjects and 5.9% of Group 2 subjects. Following multivariate regression analysis, the researchers found that subjects were significantly less likely to have good stereopsis if the VA of the pseudophakic eye was 20/60 or worse.
The researchers concluded that the factors most likely to lead to good stereopsis include later manifestation of cataract, no strabismus and achievement of good postoperative VA (≥20/40), the last of these being the most significant factor.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.